FDA clears NeuroSigma's Monarch device to treat ADHD - 0 views
-
jacob logan on 24 Apr 19The US Food and Drug Administration (FDA) has granted marketing clearance for Monarch, an external trigeminal nerve stimulation (eTNS) system developed by NeuroSigma, to treat attention deficit hyperactivity disorder (ADHD).